As in vivo cell therapies enter clinical trials, suppliers tackle the technical and logistical barriers to commercial ...

Novel approach to engineering complex microbial traits generates tens of millions of gene combinations, enabling gain-of-function traits beyond those observed from individual genes SAN DIEGO, April 8, ...

Armatus Bio, a late-preclinical stage biotech innovator developing vectorized RNAi medicines in neuromuscular disorders, today announced the publication of foundational data in Molecular Therapy ...

Desperate to help his sick dog, one Australian man went down the ultimate ChatGPT research hole, using artificial intelligence to design a personalized experimental treatment and finding top ...

A protein called LENG8 traps defective RNA molecules inside the cell nucleus before they can reach the cytoplasm and disrupt normal cellular function, according to a study published in Molecular Cell ...

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the ...

EXPLAIN ALL THIS. MINDY, WE’VE BEEN HEARING A LOT ABOUT THESE VACCINES OVER THE PAST FIVE, SIX YEARS, RIGHT? KAI RNA VACCINES GAINED A LOT OF ATTENTION DURING THE HEIGHT OF THE COVID 19 PANDEMIC. THE ...

Scientists are making rapid progress toward a long-awaited goal that could help to reshape cancer care: mRNA cancer vaccines with the potential to significantly boost the immune system’s ability to ...

SAN DIEGO, Feb. 18, 2026 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide ...

Can the weakened immune systems of older individuals be rejuvenated? Researchers from the German Cancer Research Center (DKFZ), the HI-STEM institute, and the Broad Institute have demonstrated that ...

Pfizer’s mRNA flu vaccine outperformed the standard flu shot in a Phase 3 clinical trial, according to results published Wednesday in the New England Journal of Medicine. Subscribe to read this story ...